- Home
- NKSH vs PROF Comparison
NKSH vs PROF Comparison
Compare NKSH & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKSH
- PROF
- Stock Information
- Founded
- NKSH 1891
- PROF N/A
- Country
- NKSH United States
- PROF Canada
- Employees
- NKSH N/A
- PROF N/A
- Industry
- NKSH Major Banks
- PROF Medical/Dental Instruments
- Sector
- NKSH Finance
- PROF Health Care
- Exchange
- NKSH Nasdaq
- PROF Nasdaq
- Market Cap
- NKSH 172.3M
- PROF 201.2M
- IPO Year
- NKSH N/A
- PROF N/A
- Fundamental
- Price
- NKSH $26.67
- PROF $5.76
- Analyst Decision
- NKSH Strong Buy
- PROF Strong Buy
- Analyst Count
- NKSH 1
- PROF 1
- Target Price
- NKSH $38.00
- PROF $12.00
- AVG Volume (30 Days)
- NKSH 7.9K
- PROF 66.5K
- Earning Date
- NKSH 05-14-2025
- PROF 03-06-2025
- Dividend Yield
- NKSH 5.70%
- PROF N/A
- EPS Growth
- NKSH N/A
- PROF N/A
- EPS
- NKSH 1.24
- PROF N/A
- Revenue
- NKSH $44,130,000.00
- PROF $10,680,000.00
- Revenue This Year
- NKSH $1.17
- PROF $165.23
- Revenue Next Year
- NKSH $9.78
- PROF $96.94
- P/E Ratio
- NKSH $21.89
- PROF N/A
- Revenue Growth
- NKSH N/A
- PROF 48.35
- 52 Week Low
- NKSH $26.00
- PROF $4.75
- 52 Week High
- NKSH $35.00
- PROF $11.42
- Technical
- Relative Strength Index (RSI)
- NKSH 41.40
- PROF 28.68
- Support Level
- NKSH $26.76
- PROF $4.75
- Resistance Level
- NKSH $27.90
- PROF $7.15
- Average True Range (ATR)
- NKSH 0.60
- PROF 0.50
- MACD
- NKSH 0.03
- PROF -0.11
- Stochastic Oscillator
- NKSH 33.68
- PROF 43.92
About NKSH National Bankshares Inc.
National Bankshares Inc is a bank holding company. It focuses on lending to small and mid-sized businesses and individuals. The types of loans it offers include commercial and agricultural, commercial real estate, construction for commercial and residential properties, residential real estate, home equity, and various consumer loan products. It also operates an insurance and brokerage subsidiary, National Bankshares Financial Services, Inc. The company earns its revenues from interest and fees on loans, non-interest income, and investments.
About PROF Profound Medical Corp.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.